Skip to content
by Legal Desire
25 July 2024

Freshfields Advises Grünenthal on its Acquisition of Valinor Pharma

Advising firms

Deal team

24 lawyers named
LawyerFirmSeniorityPracticeOffice
Adam Golden Freshfields Partner Corporate/M&A and Life Sciences Transactions New York
Kristen Riemenschneider Freshfields Partner Corporate/M&A and Life Sciences Transactions D.C.
Oliver Board Freshfields Partner Corporate/M&A and Life Sciences Transactions New York
Ryan Taylor Freshfields Associate Corporate/M&A and Life Sciences Transactions New York
Jake Silvers Freshfields Associate Corporate/M&A and Life Sciences Transactions New York
Chinyere Obi Freshfields Associate Corporate/M&A and Life Sciences Transactions New York
Nana Kessie Freshfields Associate Corporate/M&A and Life Sciences Transactions New York
Laura Zhu Freshfields Associate Corporate/M&A and Life Sciences Transactions New York
Tanny Kang Freshfields Associate Corporate/M&A and Life Sciences Transactions New York
Nicole Foster Freshfields Partner Executive Compensation and Benefits New York
Jeffrey Anand Freshfields Senior associate Executive Compensation and Benefits New York
Jordan Riley Freshfields Associate Executive Compensation and Benefits New York
Joe Soltis Freshfields Partner Tax New York
Brendan Counihan Freshfields Senior associate Tax D.C.
Jeremiah Nelson Freshfields Counsel Real Estate Silicon Valley
Casey Hagen Freshfields Associate Real Estate New York
Kyle Lakin Freshfields Partner Finance New York
Sonam Cheema Freshfields Senior associate Finance London
Mena Kaplan Freshfields Partner IP New York
Daniel Spencer Freshfields Senior associate IP D.C.
Meghan Rissmiller Freshfields Partner Antitrust, Competition and Trade D.C.
Rod Carlton Freshfields Partner Antitrust, Competition and Trade London
Charles Ramsey Freshfields Other Antitrust, Competition and Trade D.C.
Katie Kissinger Freshfields Associate Antitrust, Competition and Trade New York

21 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 250m (approx. $250 million)
What the figure measures
Total transaction value
Client
GrünenthalBuy-side
Counterparties
Valinor Pharma (Sell-side)